Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies

Patients with advanced solid malignancies recurrent or resistant to standard therapy have limited treatment options. The role of molecular biomarkers for predicting immune checkpoint blockade (ICB) efficacy are not well characterized in these patients. Tumor mutational profiles of 490 patients with...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Yang, Richard K., Qing, Yun, Jelloul, Fatima Zahra, Routbort, Mark J., Wang, Peng, Shaw, Kenna, Zhang, Jiexin, Lee, Jack, Medeiros, L. Jeffrey, Kopetz, Scott, Tetzlaff, Michael T., Broaddus, Russell R.
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2020
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021232/
https://ncbi.nlm.nih.gov/pubmed/32110280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27466
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items